What is typically the primary objective of conducting "post-market surveillance"?

The primary objective of conducting "post-market surveillance" is to ensure the product's long-term safety and efficacy. This process involves monitoring the health and wellness of patients after a product, such as a drug or medical device, has been approved for public use. It aims to identify any adverse effects or issues that may not have been apparent during the clinical trials, which are typically conducted on a smaller population over a limited time frame.

Post-market surveillance is critical for understanding how a product performs in the larger population, including varying demographics and long-term usage patterns. Regulatory bodies often require this ongoing monitoring to maintain the product's market presence and to ensure that any necessary updates or warnings can be effectively communicated to the public. This focus on long-term safety and efficacy helps to protect consumers and informs future modifications to the product or additional regulatory actions if needed.